Study #2021-0393
Analysis of apheresis and infusion product retains from lymphoma patients treated with standard of care axicabtagene ciloleucel
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Analysis of axi-cel retains
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Not applicable
Physician name:
Michael Green
Department:
Lymphoma/Myeloma
For general questions about clinical trials:
1-833-780-1379
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.